NCT07226180 2026-03-18
Development and Application of Patient-Derived Models of Cancer
Certis Oncology Solutions, Inc
Enrolling by invitation
Clinical Trials
14 trialsNCT00923065 2026-03-12
Data Collection, Clinical Care and Interventions in CCR, NCI
National Institutes of Health Clinical Center (CC)
Enrolling by invitation
NCT00027326 2026-03-09
Collection of Blood and Urine From Patients Undergoing Radiation Therapy
National Institutes of Health Clinical Center (CC)
Enrolling by invitation
NCT05303532 2026-02-23
ROSY-D
AstraZeneca
Phase 3 Enrolling by invitation
NCT06412029 2026-02-19
HRSN
Wake Forest University Health Sciences
Enrolling by invitation
NCT06701201 2026-02-10
A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product
Verismo Therapeutics
Enrolling by invitation
NCT07372261 2026-01-30
PORTENT
Casa Sollievo della Sofferenza IRCCS
Enrolling by invitation
NCT05741242 2026-01-15
A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors
Jaime Leandro Foundation for Therapeutic Cancer Vaccines
Phase 1/2 Enrolling by invitation
NCT07311057 2026-01-06
Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for Radiotherapy
Mashhad University of Medical Sciences
Phase 3 Enrolling by invitation
NCT07283627 2025-12-24
MBT & cancer
La Tour Hospital
Enrolling by invitation
NCT05407844 2025-11-26
Community Health Worker Based Intervention to Improve Palliative Care
Wake Forest University Health Sciences
Phase NA Enrolling by invitation
NCT06699615 2025-07-18
Assessing Perceptions of ML Explanations by Medical Oncologists
Abramson Cancer Center at Penn Medicine
Phase NA Enrolling by invitation
NCT02436941 2025-05-01
Radiation Medicine Patient Registry, Loma Linda University Medical Center
Loma Linda University
Enrolling by invitation
NCT05479708 2025-04-24
ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma
Ruijin Hospital
Enrolling by invitation